Free. Unsubscribe any time.
Emergent BioSolutions Inc. (EBS)
Emergent BioSolutions Inc. filed 11 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 6 reporting owners, covering 14 transactions and 140,816 shares. None carries the SEC's AFF10B5ONE flag; all 11 name a plan in a footnote. 7 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-07-02, came 59 days after the one before it (2026-05-04) and reports 1 transaction against 4 in the filing before it.
- The sales it reports total 3,000 shares, 14,202 fewer than the 17,202 in the filing before it.
- Its 11 plan statements rank 369th of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 4 have more plan statements on file than it, 5 have fewer and 1 has the same number.
- Its 11 filings on file run from 2025-05-28 to 2026-07-02, and state no plan adoption date.
Trades in Emergent BioSolutions Inc. 14
- Katkin Keith — 2025-05-23 · S · 7,844 shares
- Zoon Kathryn C — 2025-08-15 · S · 7,086 shares
- Glessner Coleen — 2025-10-07 · S · 30,608 shares
- Dayal Sujata Tyagi — 2025-11-07 · S · 8,552 shares
- DeGolyer Donald W — 2025-11-10 · S · 17,801 shares
- Williams Paul Anthony — 2026-04-01 · S · 4,000 shares
- Katkin Keith — 2026-04-30 · S · 15,481 shares
- Dayal Sujata Tyagi — 2026-05-01 · S · 12,781 shares
- Dayal Sujata Tyagi — 2026-05-01 · S · 980 shares
- DeGolyer Donald W — 2026-05-01 · S · 14,527 shares
- DeGolyer Donald W — 2026-05-01 · S · 954 shares
- Zoon Kathryn C — 2026-05-01 · S · 16,145 shares
Adoption dates in Emergent BioSolutions Inc. 0
Results prints in Emergent BioSolutions Inc. 7
- 2025-03-03
- 2025-05-07
- 2025-08-06
- 2025-10-29
- 2026-02-26
- 2026-04-30
- 2026-08-05
Trades before a print in Emergent BioSolutions Inc. 1
- 0 days before the 2026-04-30 print — 2026-04-30 · S · Katkin Keith · 15,481 shares
- 22 days before the 2025-10-29 print — 2025-10-07 · S · Glessner Coleen · 30,608 shares
- 29 days before the 2026-04-30 print — 2026-04-01 · S · Williams Paul Anthony · 4,000 shares
- 35 days before the 2026-08-05 print — 2026-07-01 · S · Williams Paul Anthony · 3,000 shares
- 75 days before the 2025-08-06 print — 2025-05-23 · S · Katkin Keith · 7,844 shares
- 75 days before the 2025-10-29 print — 2025-08-15 · S · Zoon Kathryn C · 7,086 shares
- 96 days before the 2026-08-05 print — 2026-05-01 · S · Dayal Sujata Tyagi · 12,781 shares
- 96 days before the 2026-08-05 print — 2026-05-01 · S · Dayal Sujata Tyagi · 980 shares
- 96 days before the 2026-08-05 print — 2026-05-01 · S · DeGolyer Donald W · 14,527 shares
- 96 days before the 2026-08-05 print — 2026-05-01 · S · DeGolyer Donald W · 954 shares
- 96 days before the 2026-08-05 print — 2026-05-01 · S · Zoon Kathryn C · 16,145 shares
- 96 days before the 2026-08-05 print — 2026-05-01 · S · Zoon Kathryn C · 1,057 shares
Interval to Emergent BioSolutions Inc.’s next reported results date
How the interval and sources are counted →
- 1within 5 days
- 1within 10 days
- 0shortest, days
- 0no later print
- Katkin Keith 2026-04-30 · S · 0 days before the 2026-04-30 print
Reported results dates on file
- 2025-03-03
- 2025-05-07
- 2025-08-06
- 2025-10-29
- 2026-02-26
- 2026-04-30
- 2026-08-05
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.